Asciminib
Asciminib (ABL001) is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM[1].
Product Specifications
CAS Number
1492952-76-7
Product Name Alternative
ABL001
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bcr-Abl
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Asciminib.html
Purity
99.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C2=NNC=C2)=C(N3C[C@H](O)CC3)N=C1)NC4=CC=C(OC(F)(Cl)F)C=C4
Molecular Formula
C20H18ClF2N5O3
Molecular Weight
449.84
Precautions
H302, H315, H319, H335
References & Citations
[1]Wylie AA, et al. The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1. Nature. 2017 Mar 30;543 (7647) :733-737.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC700391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF770 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY428853 100 µg
ABH2 (ALKBH2) (NM_001145374) Human Over-expression Lysate
Sign In for Pricing
View Details 
TP308193L 1 mg
Deleted in azoospermia 4 (DAZ4) (NM_020420) Human Recombinant Protein
Sign In for Pricing
View Details